Background Progressive lung damage causes most deaths in cystic fibrosis. Non‐steroidal
anti‐inflammatory drugs (such as ibuprofen) may prevent progressive pulmonary …

Background In cystic fibrosis, airway obstruction and recurrent respiratory infection leads to
inflammation and eventually long term lung damage,(bronchiectasis), respiratory failure and …

Background In cystic fibrosis (CF) airway obstruction and recurrent respiratory infection lead
to inflammation, long‐term lung damage, respiratory failure and death. Anti‐inflammatory …

Background Recurrent wheeze and breathlessness are common in people with cystic
fibrosis, and bronchodilators are commonly prescribed. Despite their wide‐scale and often …

Study objectives In recent years, there has been considerable interest in the use of anti-
inflammatory medications to decrease airway inflammation and preserve pulmonary function …

Background The reduction of lung inflammation is one of the goals of cystic fibrosis therapy.
Inhaled corticosteroids are often used in this respect to treat children and adults with cystic …

Background Cystic fibrosis is a genetic disorder in which abnormal mucus in the lungs is
associated with susceptibility to persistent infection. Pulmonary exacerbations are when …

Background Inhaled antibiotics are commonly used to treat persistent airway infection that
contributes to lung damage in people with cystic fibrosis (CF). Objectives To examine the …

A total of 53 national cystic fibrosis (CF) patient registry studies published between July
2008 and November 2011 have been reviewed, focusing on the following topics: CF …

Ibuprofen therapy for cystic fibrosis lung disease: revisite... : Current Opinion in Pulmonary
Medicine Ibuprofen therapy for cystic fibrosis lung disease: revisited : Current Opinion in …